Venlafaxine Hydrochloride Capsule, Extended Release
Product Images NDC 68071-3886

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Venlafaxine Hydrochloride (NDC 68071-3886). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Nucare Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Pdp (68071 3886 3)

Label for Venlafaxine Hydrochloride 75 mg extended-release capsules, packaged 30 capsules per container. The label indicates the product is distributed by Aurobindo Pharma USA, Inc. and NuCare Pharmaceuticals, Inc. It includes the NDC 68071-3886 and storage instructions to keep at 68-77°F. The label also states Rx only and warns to keep out of reach of children.*

FDA Label Image

Figure (Venlafaxine Fig1)

A scatter plot chart illustrating the fold change and 90% confidence interval for the pharmacokinetic variables Cmax and AUC of venlafaxine in special populations including hepatic impairment, renal impairment, CYP2D6 polymorphism, age over 60 years, and gender. The x-axis represents the change relative to the reference value, with data points plotted to compare venlafaxine exposure across these groups.*

FDA Label Image

Figure (Venlafaxine Fig2)

A scatterplot chart displaying fold changes with 90% confidence intervals for the pharmacokinetic parameters Cmax and AUC of venlafaxine hydrochloride when interacting with various drugs, including ethanol, diazepam, cimetidine, ketoconazole, indinavir, metoprolol, imipramine, and lithium. The x-axis represents change relative to the reference value, ranging from 0 to 3, illustrating the impact of these interacting drugs on venlafaxine exposure.*

FDA Label Image

Figure (Venlafaxine Fig3)

A chart illustrating the pharmacokinetic effects of various interacting drugs on the analyte Venlafaxine Hydrochloride, showing fold change and 90% confidence intervals for Cmax and AUC values relative to a reference. The x-axis represents the change relative to the reference value, with multiple drugs listed on the y-axis including ethanol, diazepam, alprazolam, indinavir, metoprolol, risperidone, imipramine, haloperidol, caffeine, tolbutamide, and lithium.*

FDA Label Image

Chemical Structure (Venlafaxine Str)

Chemical structure of venlafaxine hydrochloride, showing its molecular framework with labeled functional groups including a methoxyphenyl ring, cyclohexanol, and a dimethylaminoethyl side chain, along with the associated hydrochloride salt.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.